[Ray of hope for therapy of severe allergic asthma: blockade of IgE closes the treatment gap].
D000293:Adolescent; D000328:Adult; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D004311:Double-Blind Method; D006801:Humans; D007073:Immunoglobulin E / Q000187:drug effects / Q000276:immunology; D000069444:Omalizumab; D010919:Placebos; D016032:Randomized Controlled Trials as Topic
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D010919:Placebos; D000069444:Omalizumab; D007073:Immunoglobulin E